Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03572660 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM

Study acronym: DCM-Support
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
  2. Trial status: Active, Not Recruiting to Recruiting
    • Primary and study completion dates: Mar 31, 2025 to Mar 31, 2030
    • Site details revised
    v9
  3. Primary completion date: Jun 30, 2024 to Mar 31, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Mar 30, 2025 to Mar 31, 2025
    • Site details revised
    v8
  4. Primary completion date: Mar 30, 2023 to Jun 30, 2024
    • Study completion date: Jul 30, 2024 to Mar 30, 2025
    v7
  5. Eligibility criteria expanded, about 61 words
    • Secondary endpoints: 5 to 12
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary endpoint revisedv5 Show 4 more changesShow less
    • Eligibility criteria revised
    • Secondary endpoints revised (5)
    • Study description shortened, about 26 words
    • Site contact updated
  2. Primary completion date: Dec 30, 2020 to Mar 30, 2023
    • Study completion date: Jul 30, 2021 to Jul 30, 2024
    v4
  3. Primary completion date: Jul 30, 2019 to Dec 30, 2020v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 15, 2018 to Dec 24, 2018
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
DCM Support is recruiting patients with dilated cardiomyopathy and heart failure symptoms. The goal of this clinical trial is to examine whether treatment with a patient's own stem cells can improve their heart function and alleviate heart failure symptoms. * Stem cells will be collected from bone marrow in the patient's hip under local anaesthetic. * The stem cells will be infused into the arteries that supply blood to the heart under local anaesthetic. * A mini heart pump will be used to take the strain off the heart during the procedure. * The follow-up involves a phone call at 1 month and clinic visits at 3 and 12 months
Trial Details
NCT Number NCT03572660
Lead Sponsor Barts & The London NHS Trust
Conditions
(from sponsor)		 Dilated Cardiomyopathy
Related terms Cardiomyopathy, Dilated, Heart Failure
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov